Growth factor for therapeutic angiogenesis in ischemic heart disease: A meta-analysis of randomized controlled trials
Aim: This study was designed to systematically evaluate the effects of growth factor (GF) for therapeutic angiogenesis on ischemic heart disease (IHD) by pooling the results of randomized controlled trials (RCTs).Methods and Results: PubMed, EMBASE, and CENTRAL databases were searched from inception...
Main Authors: | Ling Tan, Lin-Zi Long, Hong-Zheng Li, Wen-Wen Yang, Yu-Xuan Peng, Jie-Ming Lu, Fei-Fei Liao, Xiao-Chang Ma, Hua Qu, Chang-Geng Fu, Shan-Shan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.1095623/full |
Similar Items
-
Essential oils for treating anxiety: a systematic review of randomized controlled trials and network meta-analysis
by: Ling Tan, et al.
Published: (2023-06-01) -
Association of body mass index trajectory and hypertension risk: A systematic review of cohort studies and network meta-analysis of 89,094 participants
by: Ling Tan, et al.
Published: (2023-01-01) -
Lycorine inhibits angiogenesis by docking to PDGFRα
by: Fei Lv, et al.
Published: (2022-08-01) -
Role of the TSPO–NOX4 axis in angiogenesis in glioblastoma
by: Hongxiang Jiang, et al.
Published: (2022-10-01) -
Triglyceride-glucose index and estimated 10-year risk of a first hard cardiovascular event
by: Hua Qu, et al.
Published: (2023-01-01)